Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk
Likely AI
A large peer-reviewed study published in the British Medical Journal on July 22, 2026, has found that adults using GLP-1 receptor agonist drugs — including semaglutide (Ozempic and Wegovy) and tirzepatide...
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext, image
ImageAI Generated
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/6a1b6c2a-d8dc-4abd-8885-9285f3df4e71)